News & Events

Filter Year   Keywords   > Submit

5th FDA drug approval for the GBS Venture Partners portfolio

02 / 11 / 2020

> Read More

FDA Approves Bronchitol For US Market

02 / 11 / 2020

> Read More

GBS Ventures achieves its 4th New Drug Approval from the US FDA

03 / 08 / 2020

> Read More

Otsuka Announces Positive Top-line Results from Two Phase 3 Studies of Centanafadine for the Treatment of Attention-deficit Hyperactivity Disorder (ADHD) in Adult Patients

11 / 06 / 2020

> Read More

AbbVie Completes Transformative Acquisition of Allergan

08 / 05 / 2020

> Read More

 
Displaying 5 records